SEC Company Response from HOOKIPA Pharma Inc. (HOOK) (CIK 0001760542) (HOOK) — Apr 12, 2019
HOOKIPA Pharma Inc. (HOOK) (CIK 0001760542)
Date: April 12, 2019 · CIK: 0001760542 · Accession: 0001104659-19-021117
AI Filing Summary & Sentiment
File numbers found in text: 333-230451
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Tonya K. Aldave Acceleration Request Requested Date: April 17, 2019 Requested Time: 4:00 p.m., Eastern Time
Re: HOOKIPA Pharma Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-230451
Dear Ms. Aldave:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), HOOKIPA Pharma Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to April 17, 2019, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling Robert E. Puopolo at (617) 570-1393. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: Robert E. Puopolo, by facsimile to (617) 321-4362 or by email at RPuopolo@goodwinlaw.com.
[Remainder of page left intentionally blank]
If you have any questions regarding this request, please contact Robert E. Puopolo of Goodwin Procter LLP at (617) 570-1393.
Sincerely,
HOOKIPA PHARMA INC.
Show Raw Text
CORRESP 1 filename1.htm VIA EDGAR April 12, 2019 United States Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Tonya K. Aldave Re: HOOKIPA Pharma Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-230451 Acceleration Request Requested Date: April 17, 2019 Requested Time: 4:00 p.m., Eastern Time Dear Ms. Aldave: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), HOOKIPA Pharma Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to April 17, 2019, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling Robert E. Puopolo at (617) 570-1393. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: Robert E. Puopolo, by facsimile to (617) 321-4362 or by email at RPuopolo@goodwinlaw.com. [Remainder of page left intentionally blank] If you have any questions regarding this request, please contact Robert E. Puopolo of Goodwin Procter LLP at (617) 570-1393. Sincerely, HOOKIPA PHARMA INC. /s/ Jörn Aldag Jörn Aldag Chief Executive Officer HOOKIPA Pharma Inc. cc: Reinhard Kandera, HOOKIPA Pharma Inc. Daniel Courtney, HOOKIPA Pharma Inc. Kingsley L. Taft, Esq., Goodwin Procter LLP Seo Salimi, Esq., Goodwin Procter LLP